Pharmaceutical Packaging White Papers & Articles
-
What Clinical Teams Should Know About The Benefits Of Auto-Injectors
8/20/2019
For a host of reasons, auto-injectors are becoming biopharma companies’ delivery method of choice for commercial use and late-stage clinical trials. Auto-injectors ensure that the prescribed dose of medication is delivered fully and completely,making it easier to track compliance in clinical trials.
-
Scalable Strategies For Parenteral Dosage Form Selection
12/29/2017
Understand the strategies which can be employed at the different stages of development when choosing parenteral dosage forms.
-
3 Reasons Life Science Is Turning To Passive For Cold Chain
10/19/2016
Experience has shown the transition from active shippers to passive shippers is mainly driven by three factors: cost-savings, availability, and ease of use.
-
Supplier Audits Or Bust: Six Keys To Pharma Audit Success
1/6/2014
Supply chain integrity is necessary to a pharmaceutical company’s success. When dealing with a multitude of suppliers spanning several geographies, manufacturing issues can arise if proper protocols are not in place. Specific challenges include product purity, regulatory compliance, safety, cost containment and quality assurance.
Audit processes are an integral component of supply chain management. Conducting an effective audit empowers pharmaceutical companies and their suppliers to raise performance levels and strengthen relationships while improving patient-care quality. The mutual benefits of a successful audit include:
- Supply chain continuity and reliability;
- Cost reductions;
- Improved risk management;
- Global visibility; and,
- Enhanced customer satisfaction.
-
A Chief Medical Officer’s Perspective On Selecting A CRO
5/14/2012
Santosh Vetticaden, Ph.D., M.D. is a drug development professional with over 20 years of experience spanning large pharma and biotech across multiple therapeutic areas. He has been involved in trials from Phase I-Phase IV and has been extensively involved in the design, planning, and implementation of global trials. By Rob Wright, Chief Editor, Life Science Leader magazine
-
The Case For The Use Of Point-Of-Care Testing In Pharmaceutical Clinical Trials
11/22/2011
Clinical trials that are designed to evaluate the efficacy of novel pharmaceuticals require a variety of diagnostic tests to be performed on all enrolled patients.
-
Integrative Biology: At The Tipping Point
10/7/2011
I recently met Gustavo Salem, VP and general manager of the Biological Systems Division at Agilent Technologies. Salem believes integrative biology is at a tipping point for producing major breakthroughs in the drug development. By Rob Wright, Chief Editor, Life Science Leader magazine
-
Clinical Trial Material Production And Testing: What Your CMO Is Not Telling You
6/7/2011
Manufacturing clinical trial material (CTM), and the costs for the associated fill/finish and release work, most likely are not the costliest portions of the pharmaceutical process chain. By Alexander Mello, Director, Project Management
-
White Paper: Clinical Trial Material Production And Testing: What Your CMO Is Not Telling You
6/7/2011
Manufacturing clinical trial material (CTM), and the costs for the associated fill/finish and release work, most likely are not the costliest portions of the pharmaceutical process chain. By Alexander Mello, Director, Project Management
-
White Paper: FDA Requirements For Clinical Studies In Pediatric Patients
5/11/2011
FDA rules around pediatric drug trials have been tightening, to ensure more targeted data on drug efficacy and safety in children.